Sanofi ADS share price logo

Sanofi ADS

NASDAQ: SNY

Large Cap

$43.43

+0.35

(+0.81%)

Live

as on

Sanofi ADS Stock Performance

as on August 4, 2026 at 1:13 am IST

  • Day's Low

    Day's High

    $43.21
    $43.80
    downward going graph

    0.51%

    Downside

    0.85%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $40.89
    $52.68
    downward going graph

    5.85%

    Downside

    21.30%

    Upside

    downward going graph

Sanofi ADS share price movements today

Previous Close
$43.08
Open
$43.50
Volume
354.0K
Day's Low - High
$43.21 - $43.80
52 Week Low - High
$40.89 - $52.68

Sanofi ADS Historical Returns

1 Month Return
-0.19 %
3 Month Return
-6.51 %
1 Year Return
-7.85 %
3 Year Return
-15.45 %
5 Year Return
-16.35 %

Sanofi ADS Stock Fundamentals & Key Indicators

Check Sanofi ADS market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$103.2B

EPS (TTM)

4.8804

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.12%

PE Ratio (TTM)

23.16

Industry PE ratio

-15.71875

PEG Ratio

3.7785

EBITDA

12.8B

Revenue (TTM)

47.4B

Profit Margin

15.95%

Return On Equity TTM

6.58%

Sanofi ADS Stock Valuation

Track how Sanofi ADS P/E has moved over time to understand its valuation trends.

Sanofi ADS in the last 5 years

  • Overview

  • Trends

Lowest (9.10x)

June 30, 2026

Industry (-15.72x)

August 3, 2026

Today (23.16x)

August 3, 2026

Highest (13.38x)

September 30, 2021

LowHigh

Today’s Price to Earnings Ratio: 23.16x

Sanofi ADS vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sanofi ADS with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Sanofi ADS image
Sanofi ADS
BUY$103.2B-16.35%23.1615.95%NA
Eli Lilly & Co. image
Eli Lilly & Co.
BUY$1.0T348.78%40.8134.99%0.54%
AstraZeneca PLC image
AstraZeneca PLC
BUY$263.1B194.21%25.417.02%1.8900000000000001%
ABBVIE INC. image
ABBVIE INC.
BUY$443.4B115.86%70.899.80%1.31%
Johnson & Johnson image
Johnson & Johnson
BUY$617.8B47%29.7721.48%2.0500000000000003%
See all

Stock Returns calculator for Sanofi ADS Stock including INR - Dollar returns

The Sanofi ADS stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Sanofi ADS investment value today

Current value as on today

₹1,01,009

Returns

₹1,009

(+1.01%)

Returns from Sanofi ADS Stock

-₹7,102 (-7.1%)

Dollar Impact

₹8,111 (+8.11%)

Analyst Recommendation on Sanofi ADS Stock

Based on 31 analysts

BUY

74.19%

Buy

22.58%

Hold

3.23%

Sell

Based on 31 analysts, 74.19% of analysts recommend a 'BUY' rating for Sanofi ADS. Average target price of $54.61

Sanofi ADS Share Price Target

Get share price movements and forecasts by analysts on Sanofi ADS.

What analysts predicted

20.47%UPSIDE

Target Price

$54.61

Current Price

$43.43

Analyzed by

31 Analysts

Target

$54.61

Sanofi ADS target price $54.61, a slight upside of 20.47% compared to current price of $43.43. According to 31 analysts rating.

Indian Investors' Interest in Sanofi ADS Stock

Search interest for Sanofi ADS Stock has increased by 6% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:6% versus previous 30 day period

Sanofi ADS Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
10,571
12,245
15,720
7,983
11,469
10,735
13,170
12,205
11,244
12,300
Gross Profit
7,344
8,576
11,184
5,607
8,345
7,743
9,758
8,575
8,106
9,283
Operating Income
1,236
1,595
3,635
573
2,233
1,474
3,623
-1,038
2,269
2,384
EBITDA
1,867
2,026
4,247
563
2,770
1,889
4,198
3,823
2,716
1,676
Interest Expense
247
304
265
302
213
201
227
100
178
287
Depreciation
562
499
479
209
399
378
461
538
535
552
Income Before Tax
1,093
1,416
3,581
451
2,200
1,467
3,508
-1,155
2,014
828
Income Tax Expense
104
299
737
4
481
230
680
-348
420
451
Net Income
1,231
1,197
3,125
522
2,024
3,940
2,802
-801
1,614
343
Net Profit Margin
11.65%
9.78%
19.88%
6.54%
17.65%
36.70%
21.28%
-6.56%
14.35%
2.79%

Sanofi ADS Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
36,572
42,854
40,583
41,816
45,452
44,285
42,923
45,400
46,333
46,716
Gross Profit
25,292
29,114
27,576
28,505
30,663
30,431
30,349
31,624
32,517
33,667
Operating Income
6,531
5,804
4,676
3,051
14,113
8,126
10,162
6,960
7,252
9,597
EBITDA
9,900
9,637
9,179
10,662
17,883
11,538
13,510
11,390
11,033
12,479
Interest Expense
399
333
486
536
430
377
384
512
622
626
Depreciation
-
3,686
4,279
7,452
3,684
1,580
2,053
4,792
3,586
5,678
Income Before Tax
5,811
5,616
4,904
3,007
14,137
7,837
9,992
6,115
6,758
6,020
Income Tax Expense
1,325
1,722
481
121
1,807
1,558
1,909
1,017
1,204
1,043
Net Income
4,963
9,957
4,898
3,060
14,953
7,034
8,858
5,890
5,817
7,813
Net Profit Margin
13.57%
23.24%
12.07%
7.32%
32.90%
15.89%
20.64%
12.98%
12.55%
16.72%

Sanofi ADS Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
1,113
2,815
683
1,872
3,940
2,802
-801
1,614
343
Operating Cash Flow
1,423
3,848
-
2,093
1,462
3,750
3,445
1,683
2,960
Investing Cash Flow
-3,413
-
-
-776
-
-9,043
-2,131
-2,278
-
Financing Cash Flow
89
-1,872
-
-592
-3,857
-1,148
-2,570
-1,527
-1,805
Change in Cash
-1,915
-
-
550
7,368
8,906
-1,249
-2,113
800

Sanofi ADS Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
8,434
4,306
2,754
12,294
6,223
8,371
5,400
5,496
5,574
Operating Cash Flow
7,379
5,547
7,715
7,418
10,522
10,526
10,258
9,081
12,132
Investing Cash Flow
639
-12,872
-1,212
3,588
-7,298
-2,075
-6,200
-4,407
-2,761
Financing Cash Flow
-7,902
3,934
-4,193
-6,485
-7,056
-5,821
-8,052
-5,763
-9,262
Change in Cash
42
-3,390
2,502
4,488
-3,817
2,638
-4,026
-1,269
970

Global Institutional Holdings in Sanofi ADS

Funds
Holdings
Brandes Investment Partners & Co
0.16%
Royal Bank of Canada
0.13%
T. Rowe Price Associates, Inc.
0.12%
Fisher Asset Management, LLC
0.48%
Barrow Hanley Mewhinney & Strauss LLC
0.25%
See all

Sanofi ADS News & Key Events

  • img

    Today's Timeline - 30 July

    Thu, 06:34 PM

    -

    Sanofi raises 2026 sales outlook after strong Q2 earnings, driven by Dupixent and new medicines.

    Thu, 06:51 PM

    -

    Sanofi shares drop as Phase 2 bronchiectasis trial is suspended, raising pipeline concerns.

    Thu, 09:28 PM

    -

    Sanofi's collaboration revenues rise 51% to $2.17 billion, driven by Dupixent sales.

  • img

    Today's Timeline - 30 July

    Thu, 09:35 PM

    -

    Sanofi reports Q2 adjusted earnings of $1.22, beating estimates, with strong Dupixent sales.

Insights on Sanofi ADS

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Sanofi ADS has shown positive revenue growth over the last two quarters. Revenue increased from $11.24 billion to $12.3 billion, representing an average quarter-on-quarter growth of 8.6%.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Eli Lilly & Co. has given 143.5% return, outperforming this stock by 158.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, AstraZeneca PLC has given 129.4% return, outperforming this stock by 137.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Sanofi ADS has experienced a significant decline in net profit over the last two quarters. It dropped from $1.61 billion to $342.99 million, averaging a decrease of 78.8% per quarter.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SNY stock has moved down by -2.1%

About Sanofi ADS

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
OrganisationSanofi ADS
Headquarters46, avenue de la Grande ArmEe, Paris, France, 75017
IndustryDrug Manufacturers - General
CEOMs. Belen Garijo Lopez M.D.
E-voting on sharesClick here to vote

Key Management of Sanofi ADS

Name

Title

Ms. Belen Garijo Lopez M.D.

CEO & Director

Mr. François-Xavier Roger

Executive VP & CFO

Ms. Madeleine Roach

Executive VP & Head of Business Operations

FAQs

What is Sanofi ADS share price today?

Sanofi ADS share price today is $43.43 as on . Sanofi ADS share today touched a day high of $43.80 and a low of $43.21.

What is the 52 week high and 52 week low for Sanofi ADS share?

Sanofi ADS share touched a 52 week high of $52.68 on and a 52 week low of $40.89 on . Sanofi ADS stock price today i.e. is trending at $43.43,which is 17.56% down from its 52 week high and 6.21% up from its 52 week low.

What is Sanofi ADS's market capitalisation today?

Sanofi ADS market capitalisation is $0.10T as on .

How to invest in Sanofi ADS Stock (SNY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Sanofi ADS on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sanofi ADS Shares that will get you 0.0345 shares as per Sanofi ADS share price of $43.43 per share as on August 3, 2026 at 7:43 pm IST.

What is the minimum amount required to buy Sanofi ADS Stock (SNY) from India?

Indian investors can start investing in Sanofi ADS (SNY) shares with as little as ₹95.335 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.35 in Sanofi ADS stock (as per the Rupee-Dollar exchange rate as on ). Based on Sanofi ADS share’s latest price of $43.43 as on August 3, 2026 at 7:43 pm IST, you will get 0.2303 shares of Sanofi ADS. Learn more about fractional shares .

What are the returns that Sanofi ADS has given to Indian investors in the last 5 years?

Sanofi ADS stock has given -16.35% share price returns and 28.47% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?